Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > What are we waiting for

<< Previous

Bullboard Posts

Next >>

Comment by DONOOWon Oct 10, 2021 4:45pm

105 Views

Post# 33993814

RE:What are we waiting for

BLA BLA BLA, WHEN YOU WILL GOT AN APPROVAL OR din COME TO TALK, YOU ARE PLAYING THE SAME TAPE OVER AND OVER, ASK PUMPERLAND ANOTHER NEW PUMP NEVER SEEN BEFORE !

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec